1612 related articles for article (PubMed ID: 30253809)
1. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W
Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM
Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial.
Cave AE; Chang DH; Münch GW; Steiner GZ
Trials; 2019 Jun; 20(1):345. PubMed ID: 31182153
[TBL] [Abstract][Full Text] [Related]
5. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial.
Chen Y; Zhang W; Wu H; Lao L; Xu J; Xu S
Trials; 2019 Feb; 20(1):117. PubMed ID: 30744676
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled, parallel-group 12-week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment.
Steiner-Lim GZ; Bensoussan A; Andrews-Marney ER; Al-Dabbas MA; Cave AE; Chiu CL; Christofides K; De Blasio FM; Dewsbury LS; Fagan NL; Fogarty JS; Hattom LC; Hohenberg MI; Jafar D; Karamacoska D; Lim CK; Liu J; Metri NJ; Oxenham DV; Ratajec H; Roy N; Shipton DG; Varjabedian D; Chang DH
Alzheimers Dement (N Y); 2023; 9(4):e12420. PubMed ID: 37830013
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effects between SMR/delta-ratio and beta1/theta-ratio neurofeedback training for older adults with Mild Cognitive Impairment: a protocol for a randomized controlled trial.
Marlats F; Djabelkhir-Jemmi L; Azabou E; Boubaya M; Pouwels S; Rigaud AS
Trials; 2019 Jan; 20(1):88. PubMed ID: 30696475
[TBL] [Abstract][Full Text] [Related]
8. The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trial.
Steiner GZ; Yeung A; Liu JX; Camfield DA; Blasio FM; Pipingas A; Scholey AB; Stough C; Chang DH
BMC Complement Altern Med; 2016 Jan; 16():15. PubMed ID: 26762282
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.
Shin HY; Kim HR; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
BMC Complement Med Ther; 2021 Oct; 21(1):251. PubMed ID: 34620151
[TBL] [Abstract][Full Text] [Related]
10. A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
Possemis N; Verhey F; Prickaerts J; Blokland A; Ramakers I
Trials; 2024 Mar; 25(1):162. PubMed ID: 38438923
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study.
Menczel Schrire Z; Phillips CL; Duffy SL; Marshall NS; Mowszowski L; La Monica HM; Gordon CJ; Chapman JL; Saini B; Lewis SJG; Naismith SL; Grunstein RR; Hoyos CM
BMJ Open; 2021 Feb; 11(2):e041500. PubMed ID: 33568368
[TBL] [Abstract][Full Text] [Related]
12. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.
Baker LD; Barsness SM; Borson S; Merriam GR; Friedman SD; Craft S; Vitiello MV
Arch Neurol; 2012 Nov; 69(11):1420-9. PubMed ID: 22869065
[TBL] [Abstract][Full Text] [Related]
13. Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
Karamacoska D; Chan DKY; Leung I; Liu JX; Brodaty H; Fahey PP; Bensoussan A; Chang DH
PLoS One; 2023; 18(3):e0265285. PubMed ID: 36920949
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial.
Sha Z; Zhao Z; Li N; Xiao S; Li O; Zhang J; Li Z; Xu J
BMC Complement Med Ther; 2023 Apr; 23(1):101. PubMed ID: 37013520
[TBL] [Abstract][Full Text] [Related]
15. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment.
Zhang J; Yang C; Wei D; Li H; Leung EL; Deng Q; Liu Z; Fan XX; Zhang Z
Pharmacol Res; 2019 Aug; 146():104319. PubMed ID: 31220560
[TBL] [Abstract][Full Text] [Related]
17. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
[TBL] [Abstract][Full Text] [Related]
18. Galantamine for vascular cognitive impairment.
Birks J; Craig D
Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
[TBL] [Abstract][Full Text] [Related]
19. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.
Peters O; Lorenz D; Fesche A; Schmidtke K; Hüll M; Perneczky R; Rüther E; Möller HJ; Jessen F; Maier W; Kornhuber J; Jahn H; Luckhaus C; Gertz HJ; Schröder J; Pantel J; Teipel S; Wellek S; Frölich L; Heuser I
J Nutr Health Aging; 2012; 16(6):544-8. PubMed ID: 22659994
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
